CompletedPhase 2NCT03180294
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Studying Vaginal carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NRG Oncology
- Principal Investigator
- Debra BartonNRG Oncology
- Intervention
- Bupropion 150 mg XL(drug)
- Enrollment
- 230 enrolled
- Eligibility
- 18 years · FEMALE
- Timeline
- 2017 – 2021
Study locations (30)
- Kaiser Permanente-Anaheim, Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States
- Kaiser Permanente-Baldwin Park, Baldwin Park, California, United States
- Kaiser Permanente-Bellflower, Bellflower, California, United States
- Kaiser Permanente Dublin, Dublin, California, United States
- Kaiser Permanente-Fontana, Fontana, California, United States
- Kaiser Permanente-Fremont, Fremont, California, United States
- Kaiser Permanente-Fresno, Fresno, California, United States
- Kaiser Permanente - Harbor City, Harbor City, California, United States
- Kaiser Permanente-Irvine, Irvine, California, United States
- Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
- Kaiser Permanente-Cadillac, Los Angeles, California, United States
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
- Kaiser Permanente-Modesto, Modesto, California, United States
- Kaiser Permanente-Oakland, Oakland, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03180294 on ClinicalTrials.govOther trials for Vaginal carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07407647Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal CancerOhio State University Comprehensive Cancer Center
- RECRUITINGPHASE2NCT06686043HPV Vaccine, Imiquimod, and Metformin Combination TrialBaylor College of Medicine
- ACTIVE NOT RECRUITINGNCT04713618Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation TherapyOhio State University Comprehensive Cancer Center
- ACTIVE NOT RECRUITINGNCT00791635Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic CancerM.D. Anderson Cancer Center